Himanshu Baid
#397Managing Director
57
Age
30y
Exp
30y
Tenure
7/10
Risk
🎓 B.E. Electronics & Electrical Engineering · B V B College of Engineering & Technology, Hubli
📜 — · —
🏛️ None
CompensationTBP
Personality
7
Open
8
Cons
4
Extr
5
Agre
4
Neur
Poly Medicure
Healthcare · Mid Cap
High Growth · Founder-Centric
About
Himanshu Baid is the Managing Director of Poly Medicure, a Mid Cap company in the Healthcare sector with a market cap of ₹13K Cr. A Visionary leader with 30 years of experience, he is known for intuition-driven decision-making and organic builder strategy. His focus on high-end medical devices and consistent R&D investment highlights a strategy of aggressive niche market expansion.
FAQ
What is Himanshu Baid's leadership style?
Himanshu Baid is classified as a Visionary leader. He is intuition-driven in decision-making, with a category creator motivation and startup-speed pace of execution.
What is Himanshu Baid's educational background?
Himanshu Baid holds a B.E. Electronics & Electrical Engineering from B V B College of Engineering & Technology, Hubli and a — from —.
Who is the CEO of Poly Medicure?
Himanshu Baid is the Managing Director of Poly Medicure. He has been with the company for 30 years and in the current role for 30 years.
Leadership DNA
ArchetypeVisionary
MotivationCategory Creator
CrisisRevenue Hunter
DecisionIntuition-Driven
GrowthOrganic Builder
PeopleRelationship Led
InnovationDisruptor
PaceStartup-Speed
PurposeMission-First
CustomerB2B-Enterprise
EmployerLearning Ground
BrandTechnical-Expert
FocusProduct Innovation
OrientationDeep Specialist
Leadership Evidence
“His focus on high-end medical devices and consistent R&D investment highlights a strategy of aggressive niche market expansion.”
⚡ Crisis●●●○○
Poly Medicure consistently expanded its manufacturing capacity and product launches even during the peak of the COVID-19 pandemic to capture global demand for medical disposables.
🎯 Motivation●●●●○
Baid focused the company on high-end medical consumables and specialized devices, moving from basic manufacturing to creating proprietary, innovative products that compete with global MNCs.
👥 People●●●○○
As a family-led founder, Baid maintains a tight-knit organizational structure with long-term associates and a focus on core values over purely KPI-driven corporate metrics.
📈 Growth●●●●○
The company's growth has been primarily driven by continuous investment in R&D and the setting up of multiple state-of-the-art manufacturing facilities rather than large-scale M&A.
💡 Innovation●●●●○
They pioneered the domestic manufacturing of high-end medical consumables like safety IV cannulas and specialized catheters, effectively replacing expensive imports with indigenous R&D.
🏃 Pace●●●●○
They maintain a high-frequency product launch cycle, consistently expanding their portfolio with dozens of new medical device patents and product variants annually.
🌱 Purpose●●●●○
The company's core existence is built on the mission of 'Affordable Healthcare for All' by creating high-quality, cost-effective medical devices that improve patient safety.
🏷️ Brand●●●●●
Their reputation is built on engineering precision and international quality certifications, positioning them as a highly reliable technical partner for global healthcare institutions.
🤝 Customer●●●●●
The business model is primarily focused on supplying medical consumables to hospitals, healthcare chains, and global medical device distributors rather than direct-to-consumer retail.
💼 Employer●●●○○
As a specialized medical device manufacturer, it is recognized for building deep technical expertise in precision engineering and regulatory compliance within the Indian med-tech talent pool.
📋 Mandate
Requires R&D-focused leadership to scale its portfolio of complex medical devices in a high-growth sector.
🏢 Culture●●●○○
Promoter-led high-growth entity where strategic vision is deeply tied to the founder's active management.
Financials
Revenue FY25₹2K Cr
PAT FY25₹339 Cr
Rev CAGR 5Y21.8%
OPM23%
NPM20.5%
ROE12.2%
ROCE13.5%
P/E36.9
Fwd P/E32.3
P/B4.4
D/E8.2
Promoter66.9%
Institutional21.3%
Mkt Cap₹13K Cr
Compensation
To Be Published
Data being verified from audited reports
